{"abstract": "AbbVie agreed to pay $5.8 billion to acquire Stemcentrx as it continues its big push into cancer treatment.", "web_url": "https://www.nytimes.com/2016/04/29/business/dealbook/abbvie-to-buy-cancer-treatment-start-up.html", "snippet": "AbbVie agreed to pay $5.8 billion to acquire Stemcentrx as it continues its big push into cancer treatment.", "lead_paragraph": "SAN FRANCISCO \u2014 In Silicon Valley, being a unicorn is no guarantee of financial success. But an eight-year-old drug maker focused on novel cancer treatments has landed itself and its investors a windfall by selling itself to a bigger competitor.", "source": "The New York Times", "multimedia": [{"rank": 0, "subtype": "xlarge", "caption": null, "credit": null, "type": "image", "url": "images/2016/04/29/business/29DB-ABBVIE/29DB-ABBVIE-articleLarge.jpg", "height": 400, "width": 600, "subType": "xlarge", "crop_name": "articleLarge", "legacy": {"xlarge": "images/2016/04/29/business/29DB-ABBVIE/29DB-ABBVIE-articleLarge.jpg", "xlargewidth": 600, "xlargeheight": 400}}, {"rank": 0, "subtype": "jumbo", "caption": null, "credit": null, "type": "image", "url": "images/2016/04/29/business/29DB-ABBVIE/29DB-ABBVIE-jumbo.jpg", "height": 683, "width": 1024, "subType": "jumbo", "crop_name": "jumbo", "legacy": {}}, {"rank": 0, "subtype": "superJumbo", "caption": null, "credit": null, "type": "image", "url": "images/2016/04/29/business/29DB-ABBVIE/29DB-ABBVIE-superJumbo.jpg", "height": 1365, "width": 2048, "subType": "superJumbo", "crop_name": "superJumbo", "legacy": {}}, {"rank": 0, "subtype": "thumbnail", "caption": null, "credit": null, "type": "image", "url": "images/2016/04/29/business/29DB-ABBVIE/29DB-ABBVIE-thumbStandard.jpg", "height": 75, "width": 75, "subType": "thumbnail", "crop_name": "thumbStandard", "legacy": {"thumbnail": "images/2016/04/29/business/29DB-ABBVIE/29DB-ABBVIE-thumbStandard.jpg", "thumbnailwidth": 75, "thumbnailheight": 75}}, {"rank": 0, "subtype": "thumbLarge", "caption": null, "credit": null, "type": "image", "url": "images/2016/04/29/business/29DB-ABBVIE/29DB-ABBVIE-thumbLarge.jpg", "height": 150, "width": 150, "subType": "thumbLarge", "crop_name": "thumbLarge", "legacy": {}}], "headline": {"main": "AbbVie to Buy Cancer Treatment Start-Up", "kicker": null, "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "organizations", "value": "AbbVie Inc", "rank": 1, "major": "N"}, {"name": "organizations", "value": "Stemcentrx Inc", "rank": 2, "major": "N"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": 3, "major": "N"}, {"name": "subject", "value": "Stem Cells", "rank": 4, "major": "N"}, {"name": "subject", "value": "Cancer", "rank": 5, "major": "N"}], "pub_date": "2016-04-28T13:35:16+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "subsection_name": "DealBook", "byline": {"original": "By Michael J. de la Merced and Andrew Pollack", "person": [{"firstname": "Michael", "middlename": "J.", "lastname": "de la Merced", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}, {"firstname": "Andrew", "middlename": null, "lastname": "Pollack", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 2}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/565ca511-a392-5f06-a704-32217f442ae9", "word_count": 989, "uri": "nyt://article/565ca511-a392-5f06-a704-32217f442ae9"}